Home / Insulin Aspart / Norway
NO ATC A10AB05 · updated 2 Nov 2026
Insulin Aspart shortage in Norway
Is there an Insulin Aspart shortage in Norway?
Yes. As of 2 Nov 2026, 2 Insulin Aspart products are reported short in Norway, the first since 18 Sep 2025. The company estimate for the return is 31 Dec 2026 (latest 1 Mar 2027). Main reason: increased demand.
Also short in Canada, Germany, Spain, Austria, Sweden. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | NovoRapid PumpCart 100 E/ml injeksjonsvæske, oppløsning, 5x1,6 ml sylinderampulle | Novo Nordisk A/S | 18 Sep 2025 | 1 Mar 2027 | Increased demand Uventet økt etterspørsel (delvis mangel) |
| NO | Fiasp 100 E/ml injeksjonsvæske, oppløsning i sylinderampulle, 5x1,6 ml sylinderampulle (glass) pumpcart | Novo Nordisk A/S | 24 Apr 2026 | 31 Dec 2026 | Increased demand Uventet økt etterspørsel (delvis mangel) |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).